(Q44966103)

7 December 2017

title

Cigarette smoking, psychopathology and cognitive function in first-episode drug-naive patients with schizophrenia: a case-control study (English)

1 reference

7 December 2017

1 reference

1 reference

4

1 reference

7 December 2017

X Y Zhang

1

1 reference

7 December 2017

D C Chen

2

1 reference

7 December 2017

M H Xiu

3

1 reference

7 December 2017

S C He

5

1 reference

7 December 2017

X Luo

6

1 reference

7 December 2017

L Zuo

7

1 reference

7 December 2017

R Rosenheck

8

1 reference

7 December 2017

T A Kosten

9

1 reference

7 December 2017

T R Kosten

10

1 reference

7 December 2017

language of work or name

English

0 references

publication date

13 November 2012

1 reference

7 December 2017

published in

Psychological Medicine

1 reference

7 December 2017

volume

43

1 reference

7 December 2017

issue

8

1 reference

7 December 2017

page(s)

1651-1660

1 reference

Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Effects of nicotine nasal spray on cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Physical illness and lifestyle risk factors in people with their first presentation of psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Cognitive functioning in recent onset psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Genetics of schizophrenia and smoking: an approach to studying their comorbidity based on epidemiological findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Assessing depressive symptoms in persons who die of suicide in mainland China.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Nicotine dependence and symptoms in schizophrenia: naturalistic study of complex interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Proof-of-concept trial of an alpha7 nicotinic agonist in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Inhibition of the P50 cerebral evoked response to repeated auditory stimuli: results from the Consortium on Genetics of Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

The effect of nicotine on striatal dopamine release in man: A [11C]raclopride PET study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

A critique of the dopamine hypothesis of schizophrenia and psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

The molecular and cellular neurobiology of nicotine abuse in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Schizophrenia and the alpha7 nicotinic acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Cholinergic agonists as novel treatments for schizophrenia: the promise of rational drug development for psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Premorbid tobacco smoking is associated with later age at onset in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Smoking, Genetics and Schizophrenia: Evidence for Self Medication

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Association of promoter variants in the alpha7 nicotinic acetylcholine receptor subunit gene with an inhibitory deficit found in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Prevalence and correlates of active and ever-smokers in metropolitan China

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Nicotine use in schizophrenia: the self medication hypotheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Cigarette smoking and mortality risk in people with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Serious mental illness and tobacco addiction: a model program to address this common but neglected issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Effects of nicotine on cognitive deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Cigarette smoking in male patients with chronic schizophrenia in a Chinese population: prevalence and relationship to clinical phenotypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Mortality attributable to smoking in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Smoking initiation and schizophrenia: a replication study in a Chinese Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Cigarette smoking in schizophrenia: relationship to psychopathology and medication side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Effects of smoking abstinence on visuospatial working memory function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

The genetics of sensory gating deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Why do patients with schizophrenia smoke?

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Higher rates of cigarette smoking in male adolescents before the onset of schizophrenia: a historical-prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Tobacco use in schizophrenia: a study of cotinine concentrations in the saliva of patients and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Tobacco use before, at, and after first-episode psychosis: a systematic meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

Nicotine and familial vulnerability to schizophrenia: a discordant twin study

21 January 2018

2 references

https://api.crossref.org/works/10.1017%2FS0033291712002590

21 January 2018

https://api.crossref.org/works/10.1017%2FS0033291712002590

7 January 2021

The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

7 January 2021

Effects of Cigarette Smoking on Psychopathology Scores in Patients With Schizophrenia: An Experimental Study

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

7 January 2021

Independent effects of tobacco abstinence and bupropion on cognitive function in schizophrenia.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

7 January 2021

Schizophrenia and the motivation for smoking.

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

7 January 2021

Smoking habits and plasma lipid peroxide and vitamin E levels in never-treated first-episode patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1017%2FS0033291712002590

7 January 2021

10.1017/S0033291712002590

Identifiers

DOI

1 reference

7 December 2017

1 reference